Radiotherapy With CDK4/6 Inhibitors for HR+/HER2– Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Radiotherapy with Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study
Int. J. Radiat. Oncol. Biol. Phys 2022 Jul 20;[EPub Ahead of Print], A Al-Rashdan, S Quirk, M Roumeliotis, T Abedin, CP Amaro, L Barbera, S Lupichuk, JQ CaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.